BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Streptozotocin | Streptozotocin is a monosaccharide antibiotic produced by Str. achromogenes 128 (NRRL 2697). It has antibacterial effect, and human serum and urine do not affect its activity. It can protect mice infected with Staphylococcus aureus, Pasteurella pestis and Proteus vulgaris. The same amount of antibiotic U-15774 can inhibit mouse sarcoma-180, sarcoma L5178Y, Walker-256 and Ehrlich carcinoma. Streptozotocin is a glucosamine-nitrosourea derivative, which is a DNA-methylating, carcinogenic, antibiotic and diabetes inducing agent. It is commonly used for the treatment of metastatic pancreatic islet cell carcinoma. Uses: The treatment of metastatic pancreatic islet cell carcinoma. Group: Pharmaceutical. CAS No. 18883-66-4. Pack Sizes: 1 g. Product ID: BBF-03488. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Strictosidinic acid | Strictosidinic acid is a natural compound isolated from the leaves of Psychotria myriantha. Group: Pharmaceutical. CAS No. 150148-81-5. Pack Sizes: 5 mg. Product ID: NP0274. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Strigolactone GR24 | Strigolactone GR24 is a plant hormone that stimulates and regulates shoot branching. Group: Pharmaceutical. CAS No. 76974-79-3. Pack Sizes: 50 mg. Product ID: BBF-04727. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Stylopine hydrochloride | Stylopine hydrochloride is a natural compound isolated from the leaves of Chelidonium majus L. Group: Pharmaceutical. CAS No. 96087-21-7. Pack Sizes: 5 mg. Product ID: B2703-267447. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| SU 3327 | SU 3327 is a selective inhibitor of c-Jun N-terminal kinase (JNK) (IC50 = 0.7 μM) with selectivity over p38 MAPK and Akt. SU 3327 inhibits the interaction between JNK and JIP (IC50 = 239 nM). Group: Pharmaceutical. CAS No. 40045-50-9. Pack Sizes: 100 mg. Product ID: B2693-129660. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| SU 4312 | SU 4312 is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 = 0.8 and 19.4 μM, respectively) wirth selectivity over EGFR and c-Src tyrosine kinases. Group: Pharmaceutical. CAS No. 5812-7-7. Pack Sizes: 50 mg. Product ID: B0084-357203. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| SU 4942 | SU 4942 is a modulator of tyrosine kinase signal transduction, targeting VEGF and ECGF. Group: Pharmaceutical. CAS No. 76086-99-2. Pack Sizes: 50 mg. Product ID: B0084-284846. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| SU 5201 | SU 5201 is an inhibitor of IL-2 production. Group: Pharmaceutical. CAS No. 114727-43-4. Pack Sizes: 50 mg. Product ID: B0084-284849. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| SU 5205 | SU5205 is a VEGFR2 inhibitor. Group: Pharmaceutical. CAS No. 3476-86-6. Pack Sizes: 50 mg. Product ID: B0084-284844. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| SU 5214 | SU 5214 is a modulator of tyrosine kinase signal transduction. Group: Pharmaceutical. CAS No. 186611-04-1. Pack Sizes: 50 mg. Product ID: B0084-284848. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| SU5402 | SU5402 is a potent and selective vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) inhibitor. Group: Pharmaceutical. CAS No. 215543-92-3. Pack Sizes: 100 mg. Product ID: B2693-087527. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| SU5408 | A potent, selective and cell-permeable inhibitor of VEGFR2 kinase(IC50= 70 nM) with little or no effect against receptors for platelet-derived growth factor, epidermal growth factor, or insulin-like growth factor (IC50 > 100 μM). Group: Pharmaceutical. CAS No. 15966-93-5. Pack Sizes: 25 mg. Product ID: B2693-312027. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| SU 5614 | SU4984 is a FLT3 inhibitor that induces growth arrest, apoptosis, and cell cycle arrest in Ba/F3 and AML cell lines expressing a constitutively activated FLT3. It also exhibits inhibitory effects on C-KIT, VEGFR, and PDGFR&beta. Group: Pharmaceutical. CAS No. 1055412-47-9. Pack Sizes: 25 mg. Product ID: B0084-358347. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Suavioside A | Suavioside A is extracted from the leaves of Rubus suavissimus. It has sweet taste and may be used as a sweetener. Group: Pharmaceutical. CAS No. 133740-37-1. Pack Sizes: 1 mg. Product ID: NP1728. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Succinylacetone | Succinylacetone is an inhibitor of δ-aminolevulinic acid dehydratase that inhibits heme biosynthesis. It is used as a specific marker for the inherited metabolic disease, hepatorenal tyrosinemia. Uses: Enzyme inhibitors. Group: Pharmaceutical. CAS No. 51568-18-4. Pack Sizes: 250 mg. Product ID: B0084-015144. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sucralose | Sucralose is an artificial and noncaloric sweetener, not broken down by the body. Uses: Sweetener. Group: Pharmaceutical. CAS No. 56038-13-2. Pack Sizes: 500 g. Product ID: NP4251. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sucralose Impurities | Sucralose impurities play a crucial role in the biomedical industry's quality control processes for sucralose products. Monitoring these impurities ensures the safety and efficacy of sucralose, widely used in pharmaceuticals and diabetic treatment formulations, by maintaining stringent standards and aiding in the identification of any potential toxicological concerns. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sucrose dilaurate | Sucrose dilaurate is an essential substance in the biomedical realm, takeing up a pivotal role as an emulsifier and stabilizer within drug formulations. Its profound significance lies in its efficacy to enhance drug solubility and bioavailability. Group: Pharmaceutical. CAS No. 25915-57-5. Pack Sizes: 1 g. Product ID: B1370-176965. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sucrose octasulfate octasodium salt | Sucrose octasulfate octasodium salt is an intriguing biomedical innovation with remarkable anticoagulant and anti-inflammatory attributes. This compound is predominantly harnessed to study thrombosis, thromboembolism and assorted inflammatory disorders. Group: Pharmaceutical. CAS No. 74135-10-7. Pack Sizes: 10 g. Product ID: B1999-097818. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sucrose stearate | Sucrose stearate is a sucrose fatty acids ester used as an emulsifier in many beauty applications and cosmetics. Group: Pharmaceutical. CAS No. 25168-73-4. Pack Sizes: 1 kg. Product ID: B1370-064149. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sufugolix | Sufugolix, also known as TAK-013, is a highly potent, non-peptide and orally available luteinizing hormone-releasing hormone (LHRH) receptor antagonist with an IC50 of 0.1 nM. Sufugolix was under development to treat endometriosis and uterine leiomyoma and undergone testing in a phase II clinical study in both of these indications, but was subsequently discontinued. Group: Pharmaceutical. CAS No. 308831-61-0. Pack Sizes: 100 mg. Product ID: B2693-106538. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-1 | Sugammadex-1 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292567. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex Impurities | Sugammadex Impurities, integral to the biomedical realm, serve as reference benchmarks in the meticulous quality control of Sugammadex. This drug, pivotal in reversing neuromuscular blockade amid anesthesia, demands precise impurity identification and quantification to uphold medicinal safety and efficacy during surgical interventions, thereby enhancing procedural outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R12 | Sugammadex-R12 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292569. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R18 | Sugammadex-R18 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292570. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R4 | Sugammadex-R4 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292571. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R5 | Sugammadex-R5 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292572. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R6 | Sugammadex-R6 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292573. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex-R7 | Sugammadex-R7 is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: B2694-292574. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sugammadex sodium | Sugammadex, a modified γ-cyclodextrin, with a lipophilic core and a hydrophilic periphery, is an agent for reversal of neuromuscular blockade by the agent rocuronium in general anaesthesia. Group: Pharmaceutical. CAS No. 343306-79-6. Pack Sizes: 100 mg. Product ID: B0046-475662. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulbactam Impurities | Sulbactam Impurities, as critical analytical benchmarks, are integral to the biomedical sector for validating sulbactam formulation integrity. These impurities facilitate the detection of degradation byproducts in sulbactam, a beta-lactamase antagonist essential for combating bacterial infections and amplifying the efficacy of beta-lactam antibiotic therapies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulbactam Sodium | Sulbactam is an irreversible inhibitor of β-lactamase. It binds to the enzyme and does not allow it to degrade the antibiotic. Group: Pharmaceutical. CAS No. 69388-84-7. Pack Sizes: 5 g. Product ID: BBF-04624. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulbutiamine Impurities | Sulbutiamine Impurities, integral to pharmaceutical exploration, are essential for verifying drug safety and efficacy. These compounds facilitate the detection of degradation byproducts in stability evaluations, particularly pertinent to asthenia and central nervous system therapies. Scrutiny of such impurities is vital in upholding rigorous quality benchmarks in medication formulation. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfabenzamide-[d4] | Sulfabenzamide-[d4] is the labelled analogue of Sulfabenzamide, an antimicrobial agent. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BLP-014117. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfadiazine-[13C6] | Sulfadiazine-[13C6] is the labelled analogue of Sulfadiazine, which is an antibiotic. It is commonly used to treat urinary tract infections and burns. Group: Pharmaceutical. CAS No. 1189426-16-1. Pack Sizes: 10 mg. Product ID: BLP-011698. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfadiazine-[d4] | Sulfadiazine-[d4] is the labelled analogue of Sulfadiazine. Sulfadiazine is an antibiotic. It is commonly used to treat urinary tract infections and burns. Group: Pharmaceutical. CAS No. 1020719-78-1. Pack Sizes: 10 mg. Product ID: BLP-012595. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfadiazine Impurities | Sulfadiazine Impurities act as essential reference benchmarks within pharmaceutical quality assurance. These impurities are central to refining and validating sulfadiazine's sulfonamide antibiotic compositions, vital for addressing urinary tract infections, toxoplasmosis, and various bacterial pathogens, thereby reinforcing pharmacotherapeutic efficacy and safety standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfadimethoxine-[d6] | An isotope labelled Sulfadimethoxine. Sulfadimethoxine is a sulfonamide antimicrobial medication used in veterinary medicine. Group: Pharmaceutical. CAS No. 73068-02-7. Pack Sizes: 25 mg. Product ID: BLP-013130. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfadimethoxine Impurities | Sulfadimethoxine Impurities hold significant importance in the refinement and advancement of analytical methodologies within pharmaceutical research. These impurities enable the meticulous detection, identification, and quantification of related compounds, thus safeguarding the safety and efficacy of sulfadimethoxine, a primary antibacterial agent in veterinary infection management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfadimidine-[13C6] | Sulfadimidine-[13C6] is the labelled analogue of Sulfadimidine, which is a sulfonamide antibacterial. It competitively inhibits dihydropteroate synthase and interferes with folic acid synthesis. Group: Pharmaceutical. CAS No. 77643-91-5. Pack Sizes: 10 mg. Product ID: BLP-011697. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfadimidine Impurities | Sulfadimidine Impurities hold paramount importance within the biomedical realm, facilitating quality assurance and validation studies. These impurities play a crucial role in refining sulfadimidine, an antibiotic crucial for combating bacterial infections across species. Their precise identification is vital for ensuring the drugs therapeutic efficacy and safety profile. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfadoxine-[d3] | Sulfadoxine-[d3] is the labelled analogue of Sulfadoxine, which is an antibacterial. It competitively inhibits dihydropteroate synthase and interferes with folic acid synthesis. Group: Pharmaceutical. CAS No. 1262770-70-6. Pack Sizes: 25 mg. Product ID: BLP-011696. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfadoxine-[d4] | Sulfadoxine-[d4] is the labelled analogue of Sulfadoxine. Sulfadoxine is an antibacterial. It competitively inhibits dihydropteroate synthase, interfering with folate synthesis. Group: Pharmaceutical. CAS No. 1330266-05-1. Pack Sizes: 10 mg. Product ID: BLP-012597. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfadoxine Impurities | Sulfadoxine Impurities possess a fundamental role in safeguarding the quality and safety parameters of sulfadoxine, a pivotal antimalarial agent. Through meticulous examination of these impurities, researchers can enhance therapeutic outcomes, mitigate adverse effects, and optimize clinical efficacy, providing robust defense against resistant strains of Plasmodium, thus advancing malaria treatment paradigms. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfaguanidine-[d4] | Sulfaguanidine-[d4] is the labelled analogue of Sulfaguanidine. Sulfaguanidine is a sulfonamide used as an anti-infective agent. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BLP-014116. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfalene Impurities | Sulfalene Impurities hold a vital role in the rigorous assessment and assurance of purity and effectiveness within sulfonamide antibiotic spheres, crucial for combating bacterial infections. They underpin pharmaceutical formulation, elevating stringent quality control measures vital for creating dependable therapeutic agents in infectious disease management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfamethizole-[d4] | An isotope labelled Sulfamethizole. Sulfamethizole is a sulfonamide antibiotic. It competes with PABA to bind to dihydropteroate synthetase to inhibit the synthesis of dihydrofolic acid. Group: Pharmaceutical. CAS No. 2470130-12-0. Pack Sizes: 10 mg. Product ID: BLP-013900. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfamethizole Impurities | Sulfamethizole Impurities, serving as crucial reference standards, enhance the precision and efficacy of sulfamethizole antibiotic formulations. Vital in examining bacterial therapies, notably for urinary tract infections, these impurities undergo stringent analysis to assure drug safety, regulatory compliance, and adherence, thereby reinforcing the consistency of therapeutic interventions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfamethoxazole-[d4] | Sulfamethoxazole-[d4] is the labelled analogue of Sulfamethoxazole. Sulfamethoxazole is an antibiotic and a structural analog of para-aminobenzoic acid (PABA). It competes with PABA to bind to dihydropteroate synthetase to inhibit the synthesis of dihydrofolic acid. Group: Pharmaceutical. CAS No. 1020719-86-1. Pack Sizes: 10 mg. Product ID: BLP-012599. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfamethoxazole Impurities | Sulfamethoxazole Impurities occupy a vital niche in biomedical sectors, facilitating stringent quality control and assurance processes for sulfamethoxazole-derived pharmaceuticals. Through meticulous identification and quantification, these impurities safeguard drug purity and potency, essential for combating bacterial maladies such as urinary and respiratory infections, thus bolstering therapeutic reliability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfamethoxazole-[ring-13C6] | An isotope labelled Sulfamethoxazole. Sulfamethoxazole is an antibiotic and a structural analog of para-aminobenzoic acid (PABA). It competes with PABA to bind to dihydropteroate synthetase to inhibit the synthesis of dihydrofolic acid. Group: Pharmaceutical. CAS No. 1196157-90-0. Pack Sizes: 10 mg. Product ID: BLP-009103. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfamethoxypyridazine-[d3] | Sulfamethoxypyridazine-[d3] is the labelled analogue of Sulfamethoxypyridazine, which is a long-acting sulfonamide antibiotic. It is used for treatment of Dermatitis herpetiformis. Group: Pharmaceutical. CAS No. 1172846-03-5. Pack Sizes: 10 mg. Product ID: BLP-011693. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfamethoxy pyridazine-[d4] | Isotopic labelled Sulfamethoxy pyridazine. Sulfamethoxy pyridazine is a long-acting sulfonamide antibiotic. It is used for treatment of Dermatitis herpetiformis. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: BLP-004279. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfapyridine-[d4] | Sulfapyridine-[d4] is the labelled analogue of Sulfapyridine, which could be used as an antibacterial agent. Group: Pharmaceutical. CAS No. 1189863-86-2. Pack Sizes: 10 mg. Product ID: BLP-012600. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfasalazine Impurities | Sulfasalazine Impurities occupy an essential niche within pharmaceutical realms, critical for safeguarding sulfasalazine's quality and safety, a therapeutic agent targeting rheumatoid arthritis and ulcerative colitis. Analyzing these impurities not only bolsters therapeutic efficacy but also attenuates possible adverse effects, thereby optimizing the parent compound's pharmacological profile. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulf-DBCO-NHS ester | Sulf-DBCO-NHS ester, a cutting-edge chemical reagent, finds its application in the field of biomedicine, serving as a versatile biomolecule labeling and tracking agent. Featuring a DBCO functional group, it selectively binds to the azide residues on proteins or nucleic acids. The ease of incorporation of the product into various assays and diagnostic tools makes it an ideal candidate for designing probes or conjugates. Its efficacy and efficiency have garnered great interest, and it is widely being adopted for various biomedical explorations. Group: Pharmaceutical. CAS No. 1379761-19-9. Pack Sizes: 100 mg. Product ID: B2699-064951. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfentrazone Impurities | Sulfentrazone Impurities, crucial analytical constituents within the pharmaceutical sector, enhance the assurance of sulfentrazone's purity and performance. By precise identification and quantification, these impurities refine synthetic methodologies, ensuring medicinal chemistry synergy and advancing drug development to counteract resistant phytopathogens, thus underpinning pharmaceutical progress. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfocostunolide B | Sulfocostunolide B can be found in the roots of Saussurea lappa. Group: Pharmaceutical. CAS No. 1059671-65-6. Pack Sizes: 1 mg. Product ID: NP5625. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfo-Cyanine 5 Carboxylic Acid (ethyl) | Sulfo-Cyanine 5 Carboxylic Acid (ethyl) is a highly intricate biomedical entity that is availed for imaging and diagnostics within the realm of biomedicine. Serving as a pervasive fluorescent staining agent for biomolecular labeling (e.g., proteins and nucleic acids), this multifaceted acid assumes indispensable significance across an array of scientific pursuits. From facilitating drug delivery mechanisms to efforts to discover disease and monitor complex cellular activities, it has greatly advanced research progress. Group: Pharmaceutical. CAS No. 146368-11-8. Pack Sizes: 50 mg. Product ID: F03-0022. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfometuron methyl | Sulfometuron methyl acts as an acetolactate synthase inhibitor, a herbicide, and an active antibacterial agent. Sulfometuron methyl is a substituted pyrimide compound for proteomics research. Group: Pharmaceutical. CAS No. 74222-97-2. Pack Sizes: 1 g. Product ID: B0084-076243. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfopin | Sulfopin is a selective Pin1 inhibitor. Sulfopin is a chemical probe suitable for assessment of Pin1-dependent pharmacology in cells and in vivo, and that Pin1 warrants further investigation as a potential cancer drug target. Group: Pharmaceutical. CAS No. 2451481-08-4. Pack Sizes: 100 mg. Product ID: B1370-448039. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulforaphane | Sulforaphaneis a naturally-occurring phytochemical belonging to the class of isothiocyanates. As the aglycone metabolite of glucosinolate glucoraphanin (sulforaphane glucosinolate), sulforaphane acts as an antioxidant and potent stimulator of endogenous detoxifying enzymes. This agent displays anticarcinogenic properties due to its ability to induce phase II detoxification enzymes, such as glutathione S-transferase and quinone reductase, thereby providing protection against certain carcinogens and toxic, reactive oxygen species. Broccoli sprouts contain large amounts of sulforaphane, which is also found in other cruciferous vegetables including cabbage and kale. Uses: Anti-inflammatory/antitumor. Group: Pharmaceutical. CAS No. 4478-93-7. Pack Sizes: 1 g. Product ID: NP4355. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfo-SMCC sodium | Sulfo-SMCC sodium is a commonly used hetero-bifunctional, noncleavable ADC crosslinker bearing N-hydroxysuccinimide (NHS) ester and maleimide groups to react with primary amines and sulfhydryl groups, respectively. Group: Pharmaceutical. CAS No. 92921-24-9. Pack Sizes: 100 mg. Product ID: BAT-006462. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulfuric acid isopropyl sodium salt | Sulfuric acid isopropyl sodium salt, a vital chemical component, functions as an organic synthesis catalyst. Its unparalleled proficiency in the creation of ester bonds solidifies its ubiquity in amide and nitro compound syntheses, among other organic substances. Furthermore, this chemical compound displays promising capabilities as a treatment for specific types of cancer, as well as drug-resistant tuberculosis, promoting its significance in therapeutic advancements. Group: Pharmaceutical. CAS No. 52096-25-0. Pack Sizes: 2.5 g. Product ID: B2699-068409. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulglicotide | Sulglicotide can be used for the treatment of peptic ulcer and gastro-oesophageal reflux disease. Group: Pharmaceutical. CAS No. 54182-59-1. Pack Sizes: 5 g. Product ID: B1999-071072. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulindac Impurities | Sulindac Impurities are trace compounds associated with the anti-inflammatory drug Sulindac, which is utilized in managing conditions such as osteoarthritis, rheumatoid arthritis, and familial adenomatous polyposis. Understanding these impurities is crucial for ensuring drug safety and efficacy, facilitating regulatory compliance, and furthering research in pharmaceutical formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sulpiride Impurities | Sulpiride Impurities hold substantial importance in the biomedical sector, scrutinizing the quality and therapeutic potency of Sulpiride, a renowned antipsychotic for schizophrenia and depression. These impurities are pivotal in evaluating drug purity and stability, ensuring regulatory adherence while augmenting patient safety measures in clinical applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sultamicillin Impurities | Sultamicillin Impurities, by-products arising during sultamicillin synthesis, warrant critical scrutiny in pharmaceutical science. Their examination is essential for advancing drug purity, efficacy, and safety. Through comprehensive understanding of these chemical variants, researchers aim to refine pharmaceutical formulations and reduce adverse effects, thereby optimizing therapeutic outcomes against diverse bacterial infections. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sultamicillin tosylate | Sultamicillin is a compound composed of sulbactam and ampicillin linked as a double ester. Sulbactam is a semisynthetic beta-lactamase inhibitor, which exhibits improved antibacterial activity in combination with ampicillin. Group: Pharmaceutical. CAS No. 83105-70-8. Pack Sizes: 500 mg. Product ID: B0001-078090. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sumatriptan Impurities | Sumatriptan Impurities are crucial in the quality control and research of migraine treatment drugs. They assist in understanding the purity and efficacy of Sumatriptan, a medication used to treat acute migraine attacks, by identifying and analyzing trace impurities that may affect therapeutic outcomes and patient safety. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.